The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
Open accessAbstract
Background Comprehensive long-term data on atrial fibrillation trends in men and women are scant. We aimed to provide such data through analysis of the Framingham cohort over 50 years.Methods We investigated trends in incidence, prevalence, and risk factors for atrial fibrillation and its association with stroke and mortality after onset in 9511 participants enrolled in the Framingham Heart Study between 1958 and 2007. We analysed trends within 10 year groups (1958-67, 1968-77, 1978-87, 1988-97, and 1998-2007), stratified by sex.Findings During 50 years of observation (202,417 person-years), 1544 cases of new-onset atrial fibrillation occurred (of whom 723 [47%] were women). Between 1958-67 and 1998-2007, age-adjusted prevalence of atrial fibrillation quadrupled from 20·4 to 96·2 cases per 1000 person-years in men and from 13·7 to 49·4 cases per 1000 person-years in women; age-adjusted incidence increased from 3·7 to 13·4 new cases per 1000 person-years in men and from 2·5 to 8·6 new cases per 1000 person-years in women (ptrend<0·0001 for all comparisons). For atrial fibrillation diagnosed by electrocardiograph (ECG) during routine Framingham examinations, age-adjusted prevalence per 1000 person-years increased (12·6 in 1958-67 to 25·7 in 1998-2007 in men, ptrend=0·0007; 8·1 to 11·8 in women, ptrend=0·009). However, age-adjusted incidence of atrial fibrillation by Framingham Heart Study ECGs did not change significantly with time. Although the prevalence of most risk factors changed over time, their associated hazards for atrial fibrillation changed little. Multivariable-adjusted proportional hazards models revealed a 74% (95% CI 50-86%) decrease in stroke (hazards ratio [HR] 3·77, 95% CI 1·98-7·20 in 1958-1967 compared with 1998-2007; ptrend=0·0001) and a 25% (95% CI -3-46%) decrease in mortality (HR 1·34, 95% CI 0·97-1·86 in 1958-1967 compared with 1998-2007; ptrend=0·003) in 20 years following atrial fibrillation onset.Interpretation Trends of increased incidence and prevalence of atrial fibrillation in the community were probably partly due to enhanced surveillance. Measures are needed to enhance early detection of atrial fibrillation, through increased awareness coupled with targeted screening programmes and risk factor-specific prevention.Funding NIH, NHLBI, NINDS, Deutsche Forschungsgemeinschaft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly to incidence, age-adjusted prevalence of AF has been reported to be lower in women than in men in North America and Europe (Figure 2) (Supplementary Tables S3 and S4).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertension (treated) vs. none 19 HR 1.32 (95% CI 1.08-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Heart failure vs. none 19 HR 1.43 (95% CI 0.85-2.40)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Older age 19 50-59 years 60-69 years 70-79 years 80-89 years HR: 1.00 (reference) 4.98 (95% CI 3.49-7.10) 7.35 (95% CI 5.28-10.2) 9.33 (95% CI 6.68-13.0)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Obesity 19, 208 none (BMI < 25 kg/m²) overweight (BMI 25-30 kg/m²) obese (BMI ≥ 31 kg/m²) HR: 1.00 (reference) 1.13 (95% CI 0.87-1.46)1.37 (95% CI 1.05-1.78)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Myocardial infarction vs. none 19 HR 1.46 (95% CI 1.07-1.98)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“Diabetes mellitus vs. none 19 HR 1.25 (95% CI 0.98-1.60)”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [19]
In the citing paper
“In North American and European populations, the age-adjusted incidence of AF has been estimated to be 1.5 to 2 times higher in men than in women (Supplementary Tables S1 and S2).”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Elevated body mass index, hypertension, diabetes mellitus, coronary heart disease, valvular heart disease, and heart failure (HF) constitute major risk factors for AF, but the prevalence of these risk factors vary between women and men.3–5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“Women with AF have higher prevalence of hypertension and valvular heart disease and lower prevalence of coronary heart disease than men with AF.5,11,34”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“However, in studies from North America,5 Europe,34,35 and Australia,11 women with AF are, on average, older than men.”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
In the citing paper
“In particular, body mass index has increased significantly (Figure 3).5”
From Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis (2016) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study
Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., Gillum, R. F., Kim, Y.-H., McAnulty, J. H., Zheng, Z.-J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005119 · Cited by 4,506
Self-citationExplaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Self-citation
Cited by
Sorted by citations
Items 801–900 of 1,000
Shapkina, M., Ryabikov, A. N., Викторовна, М. Е., Titarenko, A. V., Avdeeva, E., Сергеевна, М. Е., Shcherbakova, L. V., Pikhart, H., Bobák, M., & Malyutina, S. K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12010122 · Cited by 8
Brière, J., Bowrin, K., Wood, R. P., Roberts, J. S., & Tatarsky, B. A. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1290641 · Cited by 8
Incidence and outcome of atrial fibrillation: diversity throughout Europe
Rienstra, M., & Gelder, I. C. V. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1078 · Cited by 8
Chazova, I. E., Zhernakova, Y. V., Blinova, N. V., Маркова, Т. Н., Mazurina, N. V., Жиров, И. В., Uskach, T. M., Safiullina, A. A., Mironova, O. I., Elfimova, E. M., et al. (2022) · Eurasian heart journal · doi:10.38109/10.38109/2225-1685-2022-3-6-56 · Cited by 7
Serum albumin levels and risk of atrial fibrillation: a Mendelian randomization study
Chen, B., Wang, C., & Li, W. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1385223 · Cited by 7
Shakeel, I., Sharma, H. C., Hodson, J. A., Iqbal, H., Tashfeen, R., Ludman, P., Steeds, R. P., Townend, J., Doshi, S. N., & Nadir, M. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082318 · Cited by 7
The burden of atrial fibrillation on emergency medical services: A population-based cohort study
Ball, J., Mahony, E., Nehme, E., Voskoboinik, A., Hogarty, J., Dawson, L. P., Horrigan, M., Kaye, D. M., Stub, D. A., & Nehme, Z. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132397 · Cited by 7
Chandan, N., Ashok, V., Hwang, T., Lim, V. G., Lachlan, T., Eftekhari, H., McGregor, G., & Osman, F. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm27175 · Cited by 7
Balzano, N., Mascolo, A., Ruggiero, D., Rafaniello, C., Paolisso, G., Rossi, F., & Capuano, A. (2025) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241312497 · Cited by 8
Masumura, M., Ohno, A., Yoshinaga, H., Sasaki, T., Yamauchi, Y., Hachiya, H., Takahashi, A., Imai, Y., Fujita, H., Ihara, K., et al. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.70132 · Cited by 10
Bidaoui, G., Feng, H., Lim, C., Chouman, N., Assaf, A. Y. M., Bsoul, M., Younes, H., Massad, C. M., Jia, Y., Liu, Y., et al. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.07.011 · Cited by 7
Wang, J., Li, Y., Shi, S., & Bo, Y. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05284-5 · Cited by 7
Pulsed Field Ablation vs Standard Radiofrequency Ablation for Typical Atrial Flutter
Gerstenfeld, E. P., Schmidt, B., Natale, A., Nair, D. G., Saliba, W. I., Verma, A., Sommer, P., Metzner, A., Dewland, T. A., Moss, J. D., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.12.081 · Cited by 7
Escobar, C., & Camm, A. J. (2020) · EP Europace · doi:10.1093/europace/euaa324 · Cited by 7
Xu, W., Yang, Y., Zhu, J., Wu, S., Wang, J., Zhang, H., Shao, X., Mo, R., Tan, J., & Wang, J. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02773-9 · Cited by 7
Vîjan, A. E., Daha, I. C., Delcea, C., & Dan, G. (2023) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2023-0004 · Cited by 7
Shaw, J. R., Li, N., Abdulrehman, J., Stella, S. F., John, M. S., Nixon, J., Spyropoulos, A. C., Schulman, S., Wang, T., Carrier, M., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.10.028 · Cited by 7
Cinotti, E., Centracchio, J., Parlato, S., Andreozzi, E., Esposito, D., Muto, V., Bifulco, P., & Riccio, M. (2024) · Sensors · doi:10.3390/s24144432 · Cited by 7
Guo, D.-C., Chen, Z.-T., Wang, X., Gao, J., Gao, Q., Huang, Z.-G., Chen, Y., Liu, P., Wang, J., & Zhang, H. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.07.007 · Cited by 7
Zou, Q., Jiang, C. S., Lin, P., Yu, Y., Li, J., Zhao, F., Hu, H., & Sun, S. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1388024 · Cited by 7
Intelligent algorithms powered smart devices for atrial fibrillation discrimination
Xie, L., Wang, L., Mo, D., Zhang, Z., & Liang, M. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.107480 · Cited by 7
ANTITHROMBOTIC THERAPY IN ELDERLY AND SENILE AGE: AN EXPERT CONSENSUS
Tkacheva, O. N., Рунихина, Н. К., VOROBIOVA, N., Komarov, A. L., Kotovskaya, Y. V., Панченко, Е. П., Владимировна, П. Е., Frolova, E. V., & Yavelov, I. S. (2017) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2017-3-4-33 · Cited by 7
In‐hospital outcomes of STEMI patients on warfarin undergoing primary PCI
Marbach, J. A., Almufleh, A. S., Bernick, J., Blondeau, M., Osborne, C. M., Russo, J. J., Hibbert, B. M., Froeschl, M. P. V., Labinaz, M. X., Glover, C. A., et al. (2018) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.27720 · Cited by 7
High Sodium Intake Impairs Small Artery Vasoreactivity in vivo in Dahl Salt-Sensitive Rats
Li, S., Wang, Q., Chen, L., Feng, S., Wu, Y., & Yan, X.-W. (2019) · Journal of Vascular Research · doi:10.1159/000498895 · Cited by 7
Kirgizova, M. A., Batalov, R. E., Tatarsky, B. A., & Popov, S. V. (2019) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2019-34-3-13-20 · Cited by 8
Gong, K.-Z., Yan, Q.-D., Huang, R.-D., Chen, J., Chen, X., Wang, W., Xu, Z., Chen, L., Fan, L., & Zhang, F. (2020) · Medicine · doi:10.1097/md.0000000000019897 · Cited by 7
Wang, W., Lessard, D., Saczynski, J. S., Goldberg, R. J., Go, A. S., Paul, T. J., Gracia, E. A., & McManus, D. D. (2020) · PubMed · doi:10.11909/j.issn.1671-5411.2020.11.007 · Cited by 7
Wang, S., Gao, Y., Zhao, L., Hu, R., Yang, X., & Liu, Y. (2021) · Medicine · doi:10.1097/md.0000000000026020 · Cited by 7
Modifiable Risk Factors and Atrial Fibrillation: the Quest for a Personalized Approach
Matei, L.-L., Silişte, C., & Vinereanu, D. (2021) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2020.16.1.88 · Cited by 8
Trajković, N., Đorđević, D., Stanković, M. N., Petrušič, T., Bogataj, Š., & Peršič, V. (2021) · Life · doi:10.3390/life11090928 · Cited by 9
Prevalence of atrial fibrillation
Samim, D., Choffat, D., Vollenweider, P., Waeber, G., Marques-Vidal, P. M., & Méan, M. (2021) · Herz · doi:10.1007/s00059-021-05090-7 · Cited by 7
Genetically based atrial fibrillation: Current considerations for diagnosis and management
Pensa, A. V., Baman, J. R., Puckelwartz, M. J., & Wilcox, J. E. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15446 · Cited by 8
Chest Pain in the Cancer Patient
Tyebally, S. M., Ghose, A., Chen, D. H., Abiodun, A., & Ghosh, A. K. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.45 · Cited by 7
Lip, G. Y. H., Murphy, R. R., Sahiar, F., Ingall, T. J., Dhamane, A. D., Ferri, M., Hlavacek, P. R., Preib, M. T., Keshishian, A. V., Russ, C., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.29333 · Cited by 7
Whitfield, R., Ascenção, R. M. S. E. S., da Silva, G. L., Almeida, A. G., Pinto, F. J., & Caldeira, D. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02117-9 · Cited by 9
Xu, W., Song, Q., Zhang, H., Wang, J., Shao, X., Wu, S., Zhu, J., Cai, J., & Yang, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002627 · Cited by 6
Yin, M., Xu, W., Pang, J., Xie, S., Xiang, M., Shi, B., Fan, H., & Yu, G. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1213672 · Cited by 8
Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study
Xu, X., Zhang, X., Cheng, S., Li, Q., Chen, C., & Ouyang, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-47025-8 · Cited by 7
Maezono, A., Sakata, S., Hata, J., Oishi, E., Furuta, Y., Shibata, M., Ide, T., Kitazono, T., Tsutsui, H., & Ninomiya, T. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae035 · Cited by 7
Li, L., Alonso, Á., Romaguera, D., Alonso‐Gómez, Á. M., Razquín, C., Tojal‐Sierra, L., Fiol, M., Martínez‐González, M. Á., Subramanya, V., Salas‐Salvadó, J., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072132 · Cited by 9
Effect of prestroke antiplatelets use on first-ever ischaemic stroke severity and early outcome
Bembenek, J. P., Niewada, M., Karlinski, M. A., & Członkowska, A. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12804 · Cited by 7
Yang, Q., Churilov, L. P., Fan, D., Davis, S. M., & Yan, B. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.05.022 · Cited by 7
Dabigatran in nonvalvular atrial fibrillation
Mumoli, N., Mastroiacovo, D., Permunian, E. T., Vitale, J., Giorgi‐Pierfranceschi, M., Cei, M., & Dentali, F. (2017) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000524 · Cited by 7
Mochalina, N., Isma, N., Svensson, P. J., Själander, A., Carlsson, M., Juhlin, T., & Wieloch, M. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.08.004 · Cited by 7
Ryden, A., Engdahl, J., Claesson, A., Nordberg, P., Ringh, M., Hollenberg, J., & Djärv, T. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022092 · Cited by 7
Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany
Guelker, J., Bufe, A., Klues, H. G., Shin, D., Blockhaus, C., Gabriel, N.-H., Haverkamp, W., & Kroeger, K. (2018) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2018.07.019 · Cited by 7
Li, P. W. C., Yu, D. S. F., & Yan, B. B. Y. (2019) · Journal of Advanced Nursing · doi:10.1111/jan.14164 · Cited by 7
Prasitlumkum, N., Kewcharoen, J., Angsubhakorn, N., Chongsathidkiet, P., & Rattanawong, P. (2019) · Indian Heart Journal · doi:10.1016/j.ihj.2019.07.009 · Cited by 7
Arai, H., Mizukami, A., Hanyu, Y., Kawakami, T., Shimizu, Y., Hiroki, J., Yoshioka, K., Otani, H., Kuroda, S., Iwatsuka, R., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12378 · Cited by 7
Zhu, J., & Xu, J. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s293812 · Cited by 7
Nothstein, M., Luik, A., Jadidi, A., Sánchez, J., Unger, L. A., Wülfers, E. M., Dössel, O., Seemann, G., Schmitt, C., & Loewe, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.673047 · Cited by 7
An automated method for detecting atrial fat using convolutional neural network
Deepa, D., Singh, Y., Wang, M. C., & Hu, W.-C. (2021) · Proceedings of the Institution of Mechanical Engineers Part H Journal of Engineering in Medicine · doi:10.1177/09544119211029745 · Cited by 7
Baykaner, T., Pundi, K. N., Lin, B. Y., Lü, Y., DeSutter, K., Lhamo, K., Garay, G., Nunes, J. C., Morin, D. P., Sears, S. F., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.01.013 · Cited by 7
Šustr, F., Macháčková, T., Pešl, M., Svačinová, J., Trachtová, K., Stárek, Z., Kianička, B., Slabý, O., & Novák, J. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00698-x · Cited by 6
Sex disparity in referral for catheter ablation for atrial fibrillation
Gangadharan, A. A., Muhammad, L. N., Song, J., Knight, B. P., & PASSMAN, R. S. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01854-3 · Cited by 6
Ma, T., Zhu, C., Cheng, X.-J., Huang, Y.-F., Li, J.-C., Tan, Y., & Bai, Y. (2025) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2024.10.012 · Cited by 6
Jiang, Y. X., Su, D., Xiao, J., Cheng, W., Hou, Y., & Zhang, Y. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1525027 · Cited by 6
Peng, X., Wang, J., Chen, T., He, L., Li, J., Xia, S., Kong, X., Zhou, N., Long, D., Sang, C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-93338-1 · Cited by 7
Naveed, M. A., Neppala, S., Tabassum, S., Ali, A., Chigurupati, H. D., Rehan, M. O., Iqbal, R., Azeem, B., Naveed, H., Ahmed, M., et al. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.03.004 · Cited by 6
Yin, Y., Jia, S., Zheng, J., Wang, W., Wang, Z., Lin, J., Lin, W., Feng, C., Xia, S., & Ge, W. (2025) · BMC Medical Imaging · doi:10.1186/s12880-025-01740-y · Cited by 6
Effect of estrogen and testosterone on cardiac electrophysiology and atrial fibrillation
Venkatakrishnan, A., Srinivasan, D., Malik, A., Hazareh, M., Nizami, M. M. U. I., Chen, J. Y., & Ng, F. S. (2025) · Heart Rhythm O2 · doi:10.1016/j.hroo.2025.11.007 · Cited by 6
Cinotti, E., Gragnaniello, M., Parlato, S., Centracchio, J., Andreozzi, E., Bifulco, P., Riccio, M., & Esposito, D. (2025) · Sensors · doi:10.3390/s25237244 · Cited by 6
The role of Western diet and gut microbiota in the pathogenesis of cardiovascular diseases
He, Z., Liu, B., Gong, A., & Jia, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1608563 · Cited by 8
Nardi, F., Gulizia, M. M., Colivicchi, F., Abrignani, M. G., Fusco, S. A. D., Lenarda, A. D., Tano, G. D., Geraci, G., Moschini, L., Riccio, C., et al. (2017) · European Heart Journal Supplements · doi:10.1093/eurheartj/sux007 · Cited by 6
The influence of sex on early post‐operative atrial fibrillation after cardiac surgery
Veen, D., Schram‐Serban, C., & de Groot, N. M. S. (2022) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.13013 · Cited by 6
Zhang, Q., Guo, Y., Li, M., Yang, R., Yao, Y., Zhao, Y., Yin, H., Zhang, H., Liu, W., & Liu, Z. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101475 · Cited by 6
Chen, X., Cheng, S., Huang, L., Chen, X., Jin, N., Hong, J. Y., Zhao, X., & Rong, J. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.05.023 · Cited by 6
Amin, A. M., Nawlo, A. A., Ibrahim, A. A. A., Hassan, A., Saber, A., Abuelazm, M. T., & Abdelazeem, B. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00518-x · Cited by 7
Yaghoubi, M., Roumiani, P. H., Nozari, F., Simiyari, S., Azarboo, A., Tabatabaei, M. S. H. Z., Khadembashiri, M. M., & Khadembashiri, M. A. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04019-2 · Cited by 6
Artificial intelligence and atrial fibrillation: A bibliometric analysis from 2013 to 2023
Jia, B., Chen, J., Luan, Y., Wang, H., Wei, Y., & Hu, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35067 · Cited by 7
Kamioka, M., Narita, K., Watanabe, T., Watanabe, H., Makimoto, H., Okuyama, T., Yokota, A., Komori, T., Kabutoya, T., Imai, Y., et al. (2024) · Hypertension Research · doi:10.1038/s41440-024-01796-3 · Cited by 6
m6A reader YTHDF2 governs the onset of atrial fibrillation by modulating Cacna1c translation
Chen, C., Wang, G., Zou, Q., Xiong, K., Chen, Z., Shao, B., Liu, Y., Xie, D., & Ji, Y. S. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2674-2 · Cited by 6
Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation
Lim, G. K., Ibrahim, R., Mee, X. C., Abdelnabi, M. H., Pham, H. N., Habib, E., Farina, J., Lee, J. Z., Lester, S. J., Scott, L. R., et al. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16739 · Cited by 6
Prediction of unstable anticoagulation with acenocoumarol versus warfarin in atrial fibrillation
Bryk, A. H., Plens, K., & Undas, A. (2017) · Cardiology Journal · doi:10.5603/cj.a2017.0038 · Cited by 6
Park, S., & Je, N. K. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419868996 · Cited by 6
Funn og konsekvenser ved langtidsregistrering av EKG
Jortveit, J., Lislevand, T. H., Rysstad, L., Dahlslett, T., & Sjøli, B. (2020) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.19.0434 · Cited by 6
The role of phosphorylation in atrial fibrillation: a focus on mass spectrometry approaches
Safabakhsh, S., Panwar, P., Barichello, S., Sangha, S. S., Hanson, P., Petegem, F. V., & Laksman, Z. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab095 · Cited by 7
Functional genomics and epigenomics of atrial fibrillation
Victorino, J., Álvarez, A., & Manzanares, M. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.04.003 · Cited by 6
Ke, F., Huang, Y.-H., Jin, Z., Huang, L., Xiong, Q., Jia, F., Chen, Y. X., & Chen, G. (2021) · Journal of International Medical Research · doi:10.1177/03000605211014375 · Cited by 6
Chen, L., Zhou, Y., Zhou, X., Liu, L.-M., Xu, P., Zhang, X., & Tan, S. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06882-7 · Cited by 6
Kabakov, A. Y., Sengun, E., Lu, Y., Roder, K., Bronk, P., Baggett, B., Turan, N. N., Moshal, K. S., & Koren, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.672360 · Cited by 6
Wang, J., Lai, Y., Jiang, C., Bai, Y., Xu, B., Du, X., Dong, J., & Ma, C. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/1527292 · Cited by 6
RetractedSerum periostin as a predictor of early recurrence of atrial fibrillation after catheter ablation
Fang, L., Jin, H. L., Li, M., Cheng, S.-Q., & Liu, N. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02115-x · Cited by 6
Fan, Q., Zhan, Y., Zheng, M., Ma, F., Ji, L., Zhang, L., & Liu, G. (2022) · Cardiology Research and Practice · doi:10.1155/2022/2090309 · Cited by 6
Thangjui, S., Yodsuwan, R., Thyagaturu, H. S., Navaravong, L., & Zoltick, J. M. (2022) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000295 · Cited by 6
Aziz, J. N. Y., Wang, T., Siegal, D. M., Douketis, J. D., Gal, G. L., Carrier, M., & Shaw, J. R. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2022.12.016 · Cited by 6
Park, C. S., Kim, H., Lee, S., Lee, J. H., Cho, Y., Choi, E., Oh, I., & Oh, S. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01555-3 · Cited by 6
Cardiomyocyte-Targeting Peptide to Deliver Amiodarone
Zahid, M., Weber, B., Yurko, R., Islam, K., Agrawal, V., Lopuszynski, J. B., Yagi, H., & Salama, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082107 · Cited by 7
Veen, D., Verbeek, E. C., Kavousi, M., Huigen, J., Mijnen-Schra, A., Cocchieri, R., Khan, M., & de Groot, N. M. S. (2023) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2023.101262 · Cited by 6
Savickas, V., Stewart, A. J., Short, V. J., Mathie, A. A., Bhamra, S. K., Veale, E. L., & Corlett, S. A. (2023) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-023-01672-z · Cited by 6
Escribano, P., Ródenas, J., García, M., Arias, M. A., Hidalgo, V. M., Calero, S., Rieta, J. J., & Alcaraz, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25295 · Cited by 6
Lim, W., Lee, S., Choi, E., Lee, S., Han, K.-D., Oh, S., & Lip, G. Y. H. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1346414 · Cited by 6
Gong, Z., Hu, M., Yang, Y., & Yin, C. (2024) · Cancer Medicine · doi:10.1002/cam4.7067 · Cited by 4
The Risks of Exfoliative Esophagitis in Patients with Atrial Fibrillation
Tajima, H., Narasaka, T., Akutsu, D., Suzuki, H., Matsui, H., Maruo, K., Yamasaki, H., & Mizokami, Y. (2020) · Medicine · doi:10.1097/md.0000000000021681 · Cited by 6
Olbers, J., Östergren, J., Rosenqvist, M., Skúladóttir, H., Klavebäck, S., Ljungman, P. L. S., & Witt, N. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002623 · Cited by 6
Li, Y., Cai, Z., She, Y., Shen, W., Wang, T., & Luo, L. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02973-3 · Cited by 6
Younes, H., Noujaim, C., Mekhael, M., Chouman, N., Assaf, A. Y. M., Kreidieh, O., Lim, C., Marrouche, N. F., & Donnellan, E. (2023) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2172402 · Cited by 6
Zhao, Y.-T., Liu, Y., Yan, Y., Tang, Z., Duan, J., Yang, H., Song, Z., You, X.-L., & Wang, M.-G. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00812-x · Cited by 6
Miyamoto, K., Killu, A. M., Kella, D., Hodge, D. O., Kapa, S., Mulpuru, S. K., Deshmukh, A. J., Packer, D. L., Asirvatham, S. J., Munger, T. M., et al. (2018) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-018-0441-0 · Cited by 6
Zhang, Y., Jiang, Y., Hong, L., Yang, H.-J., Zhang, J.-Y., & Zhou, Y. (2019) · Medical Science Monitor · doi:10.12659/msm.913528 · Cited by 6
Metadata
- Authors
- Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., Newton-Cheh, C., Lubitz, S. A., Magnani, J. W., Ellinor, P. T., Seshadri, S., Wolf, P. A., Vasan, R. S., Benjamin, E. J., & Levy, D.
- Affiliations
- Framingham Heart Study (US)
- Boston University (US)
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Schnabel, Renate B
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 386
- Issue
- 9989
- Pages
- 154-162
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4553037
- OpenAlex
- W1924098982
- Cited by
- 1,746
- References
- 32
- Citations by year
- 2026: 126 · 2025: 209 · 2024: 253 · 2023: 192 · 2022: 198 · 2021: 155 · 2020: 145 · 2019: 141 · 2018: 120 · 2017: 110 · 2016: 76 · 2015: 20
- FWCI
- 79.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- NIH/NHLBI (contract N01-HC-25195, grant 1K23HL114724)
- NIH (grants 1RC1HL101056, HL102214, and AG028321, grant 2R01HL092577, grants 1U01HL105268-01 and KL2RR031981)
- Fondation Leducq (14CVD01) and NIH grants (1R01HL092577, 1RC1HL101056, 1R01HL102214, 1R01AG028321, R01HL104156, and 1K24HL105780)
- American Heart Association Established Investigator Award (13EIA14220013)
- Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program (SCHN 1149/3-2)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- atrial fibrillation, prevalence trends, incidence trends, sex differences, risk factors, stroke, mortality, Framingham Heart Study, electrocardiogram screening, atrial fibrillation screening, atrial fibrillation prevention, cardiovascular disease prevention, long-term cohort follow-up
- MeSH terms
- Aged, Aged, 80 and over, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Middle Aged, Mortality, Risk Factors, United States, Cohort Studies, Incidence, Prevalence, Age Distribution, Sex Distribution, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
